Literature DB >> 34244729

Macrophage phagocytosis after spinal cord injury: when friends become foes.

Jana Van Broeckhoven1, Daniela Sommer1, Dearbhaile Dooley2,3, Sven Hendrix1,4, Aimée J P M Franssen1.   

Abstract

After spinal cord injury, macrophages can exert either beneficial or detrimental effects depending on their phenotype. Aside from their critical role in inflammatory responses, macrophages are also specialized in the recognition, engulfment, and degradation of pathogens, apoptotic cells, and tissue debris. They promote remyelination and axonal regeneration by removing inhibitory myelin components and cellular debris. However, excessive intracellular presence of lipids and dysregulated intracellular lipid homeostasis result in the formation of foamy macrophages. These develop a pro-inflammatory phenotype that may contribute to further neurological decline. Additionally, myelin-activated macrophages play a crucial role in axonal dieback and retraction. Here, we review the opposing functional consequences of phagocytosis by macrophages in spinal cord injury, including remyelination and regeneration versus demyelination, degeneration, and axonal dieback. Furthermore, we discuss how targeting the phagocytic ability of macrophages may have therapeutic potential for the treatment of spinal cord injury.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CNS trauma; axonal dieback; foam cells; phagocytosis; technical challenges

Mesh:

Year:  2021        PMID: 34244729     DOI: 10.1093/brain/awab250

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  6 in total

1.  Myelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury.

Authors:  Christine B Ryan; James S Choi; Hassan Al-Ali; Jae K Lee
Journal:  Neurobiol Dis       Date:  2021-12-31       Impact factor: 5.996

Review 2.  Mitochondrial function in spinal cord injury and regeneration.

Authors:  Paula G Slater; Miguel E Domínguez-Romero; Maximiliano Villarreal; Verónica Eisner; Juan Larraín
Journal:  Cell Mol Life Sci       Date:  2022-04-13       Impact factor: 9.261

Review 3.  Perspectives in the Cell-Based Therapies of Various Aspects of the Spinal Cord Injury-Associated Pathologies: Lessons from the Animal Models.

Authors:  Małgorzata Zawadzka; Anna Kwaśniewska; Krzysztof Miazga; Urszula Sławińska
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

4.  Blockage of ERCC6 Alleviates Spinal Cord Injury Through Weakening Apoptosis, Inflammation, Senescence, and Oxidative Stress.

Authors:  Peng Zou; Xiaoping Zhang; Rui Zhang; Xin Chai; Yuanting Zhao; Erliang Li; Qian Zhang; Rongbao Yan; Junsong Yang; Bo Liao
Journal:  Front Mol Biosci       Date:  2022-02-22

5.  Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury.

Authors:  Sven Hendrix; Stefanie Lemmens; Jana Van Broeckhoven; Céline Erens; Daniela Sommer; Elle Scheijen; Selien Sanchez; Pia M Vidal; Dearbhaile Dooley; Elise Van Breedam; Alessandra Quarta; Peter Ponsaerts
Journal:  J Neuroinflammation       Date:  2022-04-29       Impact factor: 9.587

6.  Bioinformatics analysis identified apolipoprotein E as a hub gene regulating neuroinflammation in macrophages and microglia following spinal cord injury.

Authors:  Xin-Qiang Yao; Jia-Ying Chen; Zi-Han Yu; Zu-Cheng Huang; Regan Hamel; Yong-Qiang Zeng; Zhi-Ping Huang; Ke-Wu Tu; Jun-Hao Liu; Yan-Meng Lu; Zhi-Tao Zhou; Stefano Pluchino; Qing-An Zhu; Jian-Ting Chen
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.